Skip to main content
Have a personal or library account? Click to login
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies Cover

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies

Acta Pharmaceutica
Volume 71 (2021): Issue 2 (June 2021)
By: Safa Daoud,  Shada J. Alabed and  Lina A. Dahabiyeh  
Open Access
|Nov 2020
Preview
DOI: https://doi.org/10.2478/acph-2021-0016 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 163 - 174
Accepted on: Jun 2, 2020
Published on: Nov 4, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
COVID-19,
main protease,
pharmacophore,
structure-based modeling,
docking study,
remdesivir,
repurposing
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Safa Daoud, Shada J. Alabed, Lina A. Dahabiyeh, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 71 (2021): Issue 2 (June 2021)
Next article